Study finds apixaban’s safety preferable over other anticoagulant medication following assessment of respective bleeding ...
In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.
The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday. Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic ...
In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer hospitalizations for recurrence and less major bleeding than rivaroxaban or ...
Please provide your email address to receive an email when new articles are posted on . Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver ...
March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of medicines - found that Eliquis carries a clearly lower risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results